Document is current
Any future updates will be listed below
-
Authors
Shi, Xiaoyou
Sahbaie, Peyman
Guo, Tian-Zhi
Hsu, Yen-Ming
Kingery, Wade S.
Clark, J. David
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NS094438, NS094438)
Congressionally Directed Medical Research Programs (HT9425-24-1-0180)
- License Information
-
More Information
Article History
Received: 27 January 2025
Revised: 19 March 2025
Accepted: 19 March 2025
First Online: 26 March 2025
Declarations
:
: Yen-Ming Hsu is the Chief Executive Officer of AB Biosciences. The other authors have no conflicts of interest to declare.
